Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000950149-96-001608
Filing Date
1996-10-23
Accepted
1996-10-23 00:00:00
Documents
1
Group Members
DAWSON SAMBERG CAPITAL MANAGEMENT INC /CTDS INTERNATIONAL PARTNERSPEQUOT ENDOWMENT PARTNERS, INC.PEQUOT GENERAL PARTNERS
SROs
NASD

Document Format Files

Seq Description Document Type Size
1 NEOZYME II CORPORATION SCHEDULE 13D SC 13D/A 41547
  Complete submission text file 0000950149-96-001608.txt   43667
Mailing Address ONE KENDALL SQUARE BRIDGE MA 02139
Business Address TODMAN BLDG MAIN ST ROAD TOWN TORTOLA BRITISH VIRG D8 8094942065
NEOZYME II CORP (Subject) CIK: 0000884392 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-42416 | Film No.: 96646590
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 354 PEQUOT AVE SOUTHPORT CT 06490
Business Address 354 PEQUOT AVE SOUTHPORT CT 06490 2032540091
DAWSON SAMBERG CAPITAL MANAGEMENT INC /CT (Filed by) CIK: 0000906305 (see all company filings)

EIN.: 061033494 | State of Incorp.: CT | Fiscal Year End: 1231